POTS does not directly lower blood sugar the way, say, an insulin-producing tumor or a diabetes medication overdose would. There is no established mechanism by which the hallmark feature of POTS, an excessive heart rate increase on standing, pulls glucose out of the bloodstream. Yet many people with POTS report symptoms that feel exactly like low blood sugar, and a growing body of research suggests the autonomic dysfunction at the core of the condition can disrupt glucose regulation in indirect but meaningful ways. The relationship is real, but it is messier and more roundabout than a simple cause-and-effect.
How Autonomic Dysfunction Disrupts Blood Sugar Regulation
Your autonomic nervous system does far more than control your heart rate. It also plays a central role in how your body manages glucose. When the sympathetic branch fires, it tells the liver to release stored glucose and simultaneously dials down how quickly your muscles absorb that glucose from the blood. In POTS, sympathetic nervous system activity is frequently elevated or dysregulated, and this has downstream effects on insulin and blood sugar balance. Research on gut hormones in POTS has found a correlation between fasting insulin levels and blood pressure in POTS patients, which investigators attributed to this shared link through autonomic dysregulation: the same sympathetic overdrive that causes cardiovascular symptoms may also be nudging insulin dynamics in abnormal directions.1Scientific Reports. Gut hormones in POTS and their relation to hemodynamic parameters and gastrointestinal symptoms
This does not mean POTS sends blood sugar into a nosedive every time someone stands up. The effect is subtler: the autonomic system’s usual fine-tuning of glucose release and uptake loses precision. In some people this could mean exaggerated insulin surges after eating, or sluggish glucose release when the body needs fuel. The direction and severity vary from person to person, which is part of why the connection between POTS and blood sugar complaints has been so difficult to pin down clinically.
The Post-Meal Blood Sugar Crash
The most concrete evidence linking POTS-related physiology to falling blood sugar comes from what happens after a meal, specifically after consuming carbohydrates. A study measuring hormonal responses after oral glucose found that people with POTS produced significantly higher levels of C-peptide (a marker of insulin secretion), glucose-dependent insulinotropic polypeptide (GIP), peptide YY, and pancreatic polypeptide compared to controls. Of these, GIP stood out because its rise was directly tied to the worsening of upright tachycardia and the drop in stroke volume that followed the glucose load.2PubMed Central. Worsening Postural Tachycardia Syndrome is Associated with Increased Glucose Dependent Insulinotropic Polypeptide Secretion
GIP is one of the incretin hormones. Its job is to amplify the insulin signal after you eat. In POTS patients, this amplification appears to be exaggerated. More insulin secretion after a carbohydrate-heavy meal can, in susceptible people, push blood sugar lower than it should go in the hours after eating, a phenomenon sometimes called reactive or postprandial hypoglycemia. The same study found that nutrient absorption rates were comparable between POTS patients and controls, so the issue is not that food is being absorbed faster. Instead, the hormonal response to normal food absorption is overshooting.
This is an important distinction. The glucose crash that many POTS patients describe after meals is not happening because of some exotic metabolic disease. It appears to be driven by the same autonomic dysfunction that produces their cardiovascular symptoms, channeled through the gut’s hormonal signaling. The practical implication is that managing carbohydrate intake, spacing meals, and favoring lower-glycemic foods may blunt these swings, though clinical trial evidence on dietary interventions specific to this problem in POTS is still thin.
Rapid Gastric Emptying and the EDS Connection
POTS frequently coexists with hypermobile Ehlers-Danlos syndrome (hEDS), a connective tissue disorder. This overlap matters for blood sugar because hEDS brings its own set of gastrointestinal problems, and some of them directly affect glucose regulation. Gastroparesis, where the stomach empties too slowly, is one well-known complication and may be underreported in this population.3PubMed Central. An overview of Ehlers Danlos syndrome and the link between postural orthostatic tachycardia syndrome and gastrointestinal symptoms with a focus on gastroparesis But the opposite problem, rapid gastric emptying, also occurs and carries its own consequences. When food moves through the stomach too quickly, a bolus of glucose hits the small intestine all at once, triggering an outsized insulin response. A case report on hypoglycemia in hEDS specifically highlighted rapid gastric emptying as a contributor to postprandial low blood sugar.4JCEM Case Reports. Hypoglycemia Associated With Hypermobile Ehlers-Danlos Syndrome
The pathophysiology of gut symptoms in hEDS is poorly understood, but likely involves a combination of connective tissue laxity affecting the gut wall, autonomic dysfunction altering motility signals, medications, and comorbid conditions.5PubMed Central. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know For someone who has both POTS and hEDS, the autonomic component and the structural connective tissue component may each independently nudge glucose regulation off balance, and having both could amplify the effect. This is one reason why blood sugar complaints are more common in the POTS-plus-hEDS population than in POTS alone.
When the Body Cannot Fight a Dropping Blood Sugar
Even healthy people occasionally experience dips in blood sugar after a large meal or during a long gap between eating. What usually prevents these dips from becoming symptomatic is counterregulation: the body detects falling glucose and mounts a defense. The adrenal glands release epinephrine (adrenaline) and norepinephrine, the pancreas releases glucagon, and the pituitary secretes growth hormone. These hormones work together to push glucose back up before it drops low enough to cause symptoms.
In people with autonomic neuropathy, this defense system is compromised. Research in type 1 diabetes patients with autonomic neuropathy found that those with more severe nerve damage had dramatically reduced epinephrine and norepinephrine responses to falling blood sugar. The magnitude of the epinephrine response was roughly a quarter of what patients without autonomic neuropathy produced, and the threshold at which these hormones kicked in was lower, meaning the body waited longer before even attempting to respond.6PubMed. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients
This matters for POTS because a subset of POTS patients have a neuropathic form of the condition. Research using skin biopsies has found that roughly a third of POTS patients in one study met criteria for neuropathic POTS, showing reduced small nerve fiber density compared to controls.7PLoS One. Structural and Functional Small Fiber Abnormalities in the Neuropathic Postural Tachycardia Syndrome While the counterregulation study was conducted in diabetic patients rather than POTS patients specifically, the underlying principle translates: when the small nerve fibers that carry autonomic signals are damaged or dysfunctional, the body’s ability to detect and correct falling blood sugar is impaired. For someone with neuropathic POTS who also has an exaggerated insulin response after meals, a weak counterregulatory defense could allow glucose to drop lower and stay low longer than it otherwise would.
Splanchnic Blood Pooling and What Happens After Eating
POTS patients often describe their worst orthostatic symptoms as occurring after meals. Part of the explanation is blood pooling: digestion requires increased blood flow to the gut, and in POTS, the blood vessels in the splanchnic-mesenteric region (the vascular bed serving the stomach, intestines, and liver) do not constrict properly when the person stands. Gastroenterological symptoms are common in POTS, and postprandial worsening of orthostatic symptoms is a recognized pattern, likely driven by this abnormal splanchnic vasoregulation.8PubMed. Splanchnic-mesenteric capacitance bed in the postural tachycardia syndrome (POTS)
The blood pooling itself does not cause hypoglycemia. But it contributes to the postprandial symptom cluster, including lightheadedness, brain fog, nausea, and trembling, that is nearly indistinguishable from the way low blood sugar feels. When a person with POTS feels terrible after eating, it can be genuinely unclear whether the problem is blood sugar, blood flow, or both. The renin-angiotensin-aldosterone system, which helps regulate blood volume and pressure, is also abnormal in many POTS patients: one study found renin activity was significantly downregulated compared to healthy controls, and the usual inverse relationship between renin activity and blood pressure was absent.9PubMed Central. Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome This hormonal abnormality compounds the blood-pooling problem, making post-meal symptoms worse and further muddying the question of whether glucose is really the culprit.
The Symptom Overlap Problem
This is the most frustrating piece of the puzzle for people living with POTS. The symptoms of low blood sugar include palpitations, sweating, dizziness, fatigue, nausea, anxiety, brain fog, blurred vision, and loss of consciousness. The symptoms of a POTS flare include palpitations, sweating, dizziness, fatigue, nausea, anxiety, brain fog, blurred vision, and sometimes loss of consciousness. The overlap is nearly total.4JCEM Case Reports. Hypoglycemia Associated With Hypermobile Ehlers-Danlos Syndrome
Because of this, people with POTS may attribute symptom episodes to low blood sugar when their glucose is actually normal, or conversely, may dismiss genuine hypoglycemic episodes as “just a POTS thing.” Careful documentation of glucose at the time of symptoms is necessary to tell the two apart. Venous blood draws are preferred over finger-stick or continuous glucose monitors for diagnostic purposes, because alterations in blood flow, which POTS inherently involves, can reduce the accuracy of capillary and sensor glucose measurements, potentially giving falsely low readings. Professional continuous glucose monitoring with a symptom and meal diary can help identify patterns but is not considered diagnostic on its own.
The clinical standard for confirming hypoglycemia is still the Whipple triad: symptoms consistent with low blood sugar, a documented low glucose at the time of those symptoms, and resolution of symptoms when glucose is corrected. Given the symptom overlap, meeting this standard in POTS takes deliberate effort and a clinician who understands that the two conditions can mask each other.
Mast Cells and Glucose Tolerance
Mast cell activation syndrome (MCAS) is another condition that frequently appears alongside POTS, forming part of the triad sometimes called the “trifecta” with POTS and hEDS. Mast cells are immune cells that release histamine and other mediators, and their activation can produce flushing, gastrointestinal distress, and drops in blood pressure. Animal research has shown that mast cells can impair glucose tolerance through stress-related pathways. In a mouse model, chronic mild stress activated mast cells via corticotropin-releasing hormone (CRH), and this led to disrupted glucose homeostasis. Treatment with an antihistamine improved glucose tolerance, suggesting the mast cells were actively worsening it.10PubMed Central. Mast cell involvement in glucose tolerance impairment caused by chronic mild stress with sleep disturbance
Translating mouse data directly to humans requires caution, but for POTS patients with concurrent MCAS, the possibility that mast cell degranulation episodes could worsen blood sugar regulation is plausible and consistent with reported experiences. Some patients describe their worst blood sugar swings as occurring alongside flushing episodes or after exposure to known mast cell triggers. This remains an area where clinical data is sparse, but the biological rationale is sound enough that clinicians familiar with the POTS-MCAS overlap increasingly screen for glucose abnormalities during symptom flares.
The “Hypoglycemic Flash” Hypothesis
A newer concept in the literature proposes that some of the episodes POTS patients attribute to low blood sugar may be triggered not by how low glucose goes, but by how fast it drops. The “Hypoglycemic Flash” hypothesis suggests that a rapid decline in blood glucose can activate the sympathoadrenal system even when the absolute glucose value stays within the normal range, because the rate of change is what the body perceives as a threat.11Elsevier / Medical Hypotheses. Hypoglycemic Flash as a potential shared metabolic trigger for episodic autonomic disorders
If this hypothesis holds up, it would explain a common frustration among POTS patients: feeling all the symptoms of a blood sugar crash while a glucose meter shows a number in the 70s or low 80s, technically normal. The idea is that a rapid fall from, say, 120 to 78 mg/dL after a meal could provoke adrenaline release and autonomic symptoms even though the landing zone is above the clinical cutoff for hypoglycemia. For someone whose sympathetic nervous system is already hyperactive, as in POTS, that adrenaline surge on top of baseline overdrive could produce a particularly miserable episode. The hypothesis is still in its early stages and has not been validated in controlled trials, but it offers a framework that fits many patients’ lived experience better than the traditional definition of hypoglycemia does.
Practical Considerations for Testing and Management
If you have POTS and suspect blood sugar issues, the first step is getting accurate measurements during actual symptom episodes. A glucose reading taken two hours after a bad spell is not very useful. Some practical considerations worth knowing:
- Finger-stick accuracy: Poor circulation in the extremities, common in POTS, can make capillary glucose readings unreliable. Cold fingers or blood pooling in the hands may yield falsely low numbers. A venous blood draw during symptoms is more trustworthy for diagnosis.
- Continuous glucose monitors: These can be helpful for spotting trends, like whether your glucose consistently dips two hours after meals, but the same blood-flow issues that affect finger sticks can affect sensor accuracy. Use them as pattern-finding tools, not diagnostic devices.
- Meal composition: Many POTS patients find that smaller meals with moderate protein and fat, rather than large carbohydrate-heavy ones, reduce both their orthostatic symptoms and their blood sugar swings. This aligns with the research showing exaggerated incretin and insulin responses to glucose loads in POTS.
- Timing of symptoms: Tracking whether your worst episodes coincide with meals, fasting, exercise, or standing can help your clinician distinguish between postprandial glucose drops, orthostatic blood-flow issues, and other causes.
The endocrinological workup for recurrent hypoglycemia, including fasting glucose and insulin levels, C-peptide, and sometimes a supervised fast or mixed-meal tolerance test, is the same whether or not you have POTS. But finding a provider who understands that POTS symptoms can mask or mimic glucose problems is often the harder challenge.
Why Standard Lab Work Sometimes Misses the Problem
A frustrating reality for many POTS patients is that standard metabolic panels come back normal. Fasting glucose, hemoglobin A1c, and even oral glucose tolerance tests may not capture what is happening during real-world symptom episodes. This is because the glucose dysregulation in POTS tends to be situational rather than chronic. Your fasting glucose in a quiet lab may be perfectly fine, while your post-meal glucose after standing in a hot kitchen drops sharply enough to produce symptoms.
The exaggerated GIP and insulin responses documented in POTS patients after oral glucose suggest that a standard oral glucose tolerance test could actually be useful if the protocol includes frequent glucose measurements over two to three hours and simultaneous heart rate monitoring.2PubMed Central. Worsening Postural Tachycardia Syndrome is Associated with Increased Glucose Dependent Insulinotropic Polypeptide Secretion The problem is that many clinicians stop collecting glucose measurements at the two-hour mark, which may be before the reactive dip has occurred. Asking for extended monitoring during a tolerance test, or wearing a continuous glucose monitor for a week while keeping a symptom diary, can fill in the gaps that a single fasting lab draw cannot.
The broader takeaway is that POTS does not cause hypoglycemia the way an endocrine tumor or medication error would. But the autonomic dysfunction, exaggerated hormonal responses, impaired counterregulation, and overlapping conditions that travel with POTS create a landscape where blood sugar instability is genuinely more likely. The challenge is distinguishing real glucose drops from symptom mimicry, and then identifying which of several possible mechanisms is driving the problem in any given patient.